Combination effect of anti-rheumatic medications for coronary artery diseases risk in rheumatoid arthritis: a nationwide population-based cohort study

References

• Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Ruddy S, Harris E, Sledge C, editors. Kelly’s textbook of rheumatology. 6th ed. Philadelphia, PA: WB Saunders; 2001. p 921-66
   Google Scholar
• Kaplan MJ. Cardiovascular complications of rheumatoid arthritis—assessment, prevention and treatment. Rheum Dis Clin North Am 2010;36:405-26
   PubMed Web of Science ®Google Scholar
• Linos A, Worthington JW, O’Fallon WM, et al. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111:87-98
   PubMed Web of Science ®Google Scholar
• Silman AJ, Hochberg MC. Epidemiology of the rheumatic diseases. 2nd edn. Oxford: Oxford University Press; 2001
   Google Scholar
• Lai CH, Lai MS, Lai KL, et al. Nationwide population-based epidemiologic study of rheumatoid arthritis in Taiwan. Clin Exp Rheumatol 2012;30:358-63
   PubMed Web of Science ®Google Scholar
• Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94
   PubMed Web of Science ®Google Scholar
• Prior P, Symmons DP, Scott DL, et al. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9
   PubMedGoogle Scholar
• Jacobsson LT, Knowler WC, Pillemer S, et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993;36:1045-53
   PubMed Web of Science ®Google Scholar
• Wong JB, Ramey DR, Singh G. Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum 2001;44:2746-9
   PubMed Web of Science ®Google Scholar
• Krishnan E, Fries JF. Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of 3035 patients. Am J Med 2003;115:371-6
   PubMed Web of Science ®Google Scholar
• Myasoedova E, Davis JM 3rd, Crowson CS, et al. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 2010;12:379-85
   PubMedGoogle Scholar
• Castañeda S, Nurmohamed MT, González-Gay MA. Cardiovascular disease in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 2016;30:851-69
   PubMed Web of Science ®Google Scholar
• Meune C, Touze E, Trinquart L, et al. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009;48:1309-13
   PubMed Web of Science ®Google Scholar
• Meune C, Touzé E, Trinquart L, et al. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis 2010;103:253-61
   PubMed Web of Science ®Google Scholar
• Crowson CS, Liao KP, Davis JM 3rd, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J 2013;166:622-8
   PubMed Web of Science ®Google Scholar
• Ogdie A, Yu Y, Haynes K, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 2015;74:326-32
   PubMed Web of Science ®Google Scholar
• Corrales A, Parra JA, González-Juanatey C, et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than coronary artery calcification score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 2013;72:1764-70
   PubMed Web of Science ®Google Scholar
• Corrales A, González-Juanatey C, Peiró ME, et al. Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 2014;73:722-7
   PubMed Web of Science ®Google Scholar
• Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7
   PubMed Web of Science ®Google Scholar
• Mackey RH, Kuller LH, Deane KD, et al. Rheumatoid arthritis, anti-CCP positivity, and cardiovascular disease risk in the Women’s Health Initiative. Arthritis Rheumatol 2015;67:2311-22
   PubMed Web of Science ®Google Scholar
• del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45
   PubMed Web of Science ®Google Scholar
• Chung CP, Oeser A, Avalos I, et al. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2006;8:R186
   PubMed Web of Science ®Google Scholar
• Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017;76:17-28
   PubMed Web of Science ®Google Scholar
• Houri Levi E, Watad A, Whitby A, et al. Coexistence of ischemic heart disease and rheumatoid arthritis patients—a case control study. Autoimmun Rev 2016;15:393-6
   PubMed Web of Science ®Google Scholar
• López-Mejías R, Castañeda S, González-Juanatey C, et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun Rev 2016;15:1013-30
   PubMed Web of Science ®Google Scholar
• Aubry MC, Maradit-Kremers H, Reinalda MS, et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007;34:937-42
   PubMed Web of Science ®Google Scholar
• van Halm VP, Nurmohamed MT, Twisk JW, et al. Disease modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 2006;8:R151
   PubMed Web of Science ®Google Scholar
• Suissa S, Bernatsky S, Hudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum 2006;55:531-6
   PubMed Web of Science ®Google Scholar
• Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008;10:R30
   PubMed Web of Science ®Google Scholar
• Cheng TM. Taiwan’s new national health insurance program: genesis and experience so far. Health Affairs 2003;22:61-76
   PubMed Web of Science ®Google Scholar
• Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer Science & Business Media; 2000
   Google Scholar
• R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015. Available at: http://www.R-project.org/ [Last accessed April 16, 2015]
   Google Scholar
• Chenevard R, Hürlimann D, Béchir M, et al. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 2003;107:405-9
   PubMed Web of Science ®Google Scholar
• Hermann M, Camici G, Fratton A, et al. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation 2003;108:2308-11
   PubMed Web of Science ®Google Scholar
• Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995;75:71B-74B
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interactions. J Am Coll Cardiol 1994;24:1468-74
   PubMed Web of Science ®Google Scholar
• Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction and adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906
   PubMed Web of Science ®Google Scholar
• Halcox JPJ, Schenk WH, Zalos G, et al. Prognostic value of coronary vascular endothelial function. Circulation 2002;106:653-8
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, et al. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003;114:647-52
   PubMed Web of Science ®Google Scholar
• Munro R, Morrison E, McDonald AG, et al. Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis 1997;56:374-7
   PubMed Web of Science ®Google Scholar
• Achuthan S, Ahluwalia J, Shafiq N, et al. Hydroxychloroquine’s efficacy as an antiplatelet agent study in healthy volunteers: a proof of concept study. J Cardiovasc Pharmacol Ther 2015;20:174-80
   PubMed Web of Science ®Google Scholar
• Prodanowich S, Ma F, Taylor JR, et al. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005;52:262-7
   PubMed Web of Science ®Google Scholar
• Bhosale UA, Quraishi N, Yegnanarayan R, et al. A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital. Niger Med J 2014;55:417-22
   PubMedGoogle Scholar
• Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8
   PubMed Web of Science ®Google Scholar
• Bresalier RS, Sandler RS, Quan H, et al. for the Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092-102
   Google Scholar
• Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016;375:2519-29
   PubMed Web of Science ®Google Scholar
• FitzGerald GA. Imprecision: limitations to interpretation of a large randomized clinical trial. Circulation 2017;135:113-15
   PubMed Web of Science ®Google Scholar
• Grosser T. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2017;376:1389-90
   PubMed Web of Science ®Google Scholar
• Copeland KT, Checkoway H, McMichael AJ, et al. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105:488-95
   PubMed Web of Science ®Google Scholar